{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:04:07Z","timestamp":1787882647830,"version":"build-2784847793"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL142971"],"award-info":[{"award-number":["HL142971"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["130750-03S1"],"award-info":[{"award-number":["130750-03S1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX004443"],"award-info":[{"award-number":["BX004443"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pflugers Arch - Eur J Physiol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00424-020-02488-w","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T03:02:46Z","timestamp":1604458966000},"page":"611-622","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Editing of the myosin phosphatase regulatory subunit suppresses angiotensin II induced hypertension via sensitization to nitric oxide mediated vasodilation"],"prefix":"10.1007","volume":"473","author":[{"given":"Myo","family":"Htet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanine A.","family":"Ursitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8785-2227","authenticated-orcid":false,"given":"Steven A.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,4]]},"reference":[{"key":"2488_CR1","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","volume":"139","author":"EJ Benjamin","year":"2019","unstructured":"Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Jordan LC, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, O\u2019Flaherty M, Pandey A, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Spartano NL, Stokes A, Tirschwell DL, Tsao CW, Turakhia MP, VanWagner LB, Wilkins JT, Wong SS, Virani SS (2019) Heart Disease and Stroke Statistics 2019 Update: A Report From the American Heart Association. Circulation 139:e56\u2013e528","journal-title":"Circulation"},{"key":"2488_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.copbio.2018.03.007","volume":"52","author":"AK Brooks","year":"2018","unstructured":"Brooks AK, Gaj T (2018) Innovations in CRISPR technology. Curr Opin Biotechnol 52:95\u2013101","journal-title":"Curr Opin Biotechnol"},{"key":"2488_CR3","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1124\/pr.115.010652","volume":"68","author":"FV Brozovich","year":"2016","unstructured":"Brozovich FV, Nicholson CJ, Degen CV, Gao YZ, Aggarwal M, Morgan KG (2016) Mechanisms of vascular smooth muscle contraction and the basis for pharmacologic treatment of smooth muscle disorders. Pharmacol Rev 68:476\u2013532","journal-title":"Pharmacol Rev"},{"key":"2488_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/micc.12097","volume":"21","author":"RP Dippold","year":"2014","unstructured":"Dippold RP, Fisher SA (2014) Myosin phosphatase isoforms as determinants of smooth muscle contractile function and calcium sensitivity of force production. Microcirculation 21:239\u2013248","journal-title":"Microcirculation"},{"key":"2488_CR5","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1161\/CIRCULATIONAHA.117.028021","volume":"137","author":"CA Emdin","year":"2018","unstructured":"Emdin CA, Khera AV, Klarin D, Natarajan P, Zekavat SM, Nomura A, Haas M, Aragam K, Ardissino D, Wilson JG, Schunkert H, McPherson R, Watkins H, Elosua R, Bown MJ, Samani NJ, Baber U, Erdmann J, Gormley P, Palotie A, Stitziel NO, Gupta N, Danesh J, Saleheen D, Gabriel S, Kathiresan S (2018) Phenotypic consequences of a genetic predisposition to enhanced nitric oxide signaling. Circulation 137:222\u2013232","journal-title":"Circulation"},{"key":"2488_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1540\/jsmr.53.1","volume":"53","author":"M Eto","year":"2017","unstructured":"Eto M, Kitazawa T (2017) Diversity and plasticity in signaling pathways that regulate smooth muscle responsiveness: paradigms and paradoxes for the myosin phosphatase, the master regulator of smooth muscle contraction. J Smooth Muscle Res 53:1\u201319","journal-title":"J Smooth Muscle Res"},{"key":"2488_CR7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1152\/physiolgenomics.00111.2010","volume":"42A","author":"SA Fisher","year":"2010","unstructured":"Fisher SA (2010) Vascular smooth muscle phenotypic diversity and function. Physiol Genomics 42A:169\u2013187","journal-title":"Physiol Genomics"},{"key":"2488_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/bs.apha.2016.07.003","volume":"78","author":"SA Fisher","year":"2017","unstructured":"Fisher SA (2017) Smooth muscle phenotypic diversity: effect on vascular function and drug responses. Adv Pharmacol 78:383\u2013415","journal-title":"Adv Pharmacol"},{"key":"2488_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.abb.2011.01.018","volume":"510","author":"ME Grassie","year":"2011","unstructured":"Grassie ME, Moffat LD, Walsh MP, MacDonald JA (2011) The myosin phosphatase targeting protein (MYPT) family: a regulated mechanism for achieving substrate specificity of the catalytic subunit of protein phosphatase type 1delta. Arch Biochem Biophys 510:147\u2013159","journal-title":"Arch Biochem Biophys"},{"key":"2488_CR10","doi-asserted-by":"publisher","first-page":"37211","DOI":"10.1074\/jbc.R400018200","volume":"279","author":"DJ Hartshorne","year":"2004","unstructured":"Hartshorne DJ, Ito M, Erdodi F (2004) Role of protein phosphatase type 1 in contractile functions: myosin phosphatase. J Biol Chem 279:37211\u201337214","journal-title":"J Biol Chem"},{"key":"2488_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1074\/jbc.M308496200","volume":"279","author":"QQ Huang","year":"2004","unstructured":"Huang QQ, Fisher SA, Brozovich FV (2004) Unzipping the role of myosin light chain phosphatase in smooth muscle cell relaxation. J Biol Chem 279:597\u2013603","journal-title":"J Biol Chem"},{"key":"2488_CR12","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1161\/HYPERTENSIONAHA.119.12619","volume":"73","author":"K-G Huo","year":"2019","unstructured":"Huo K-G, Richer C, Berillo O, Mahjoub N, Fraulob-Aquino Julio C, Barhoumi T, Ouerd S, Coelho Suellen C, Sinnett D, Paradis P, Schiffrin Ernesto L (2019) miR-431-5p knockdown protects against angiotensin II-induced hypertension and vascular injury. Hypertension 73:1007\u20131017","journal-title":"Hypertension"},{"key":"2488_CR13","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1097\/01.ASN.0000035087.11758.ED","volume":"13","author":"N Kawada","year":"2002","unstructured":"Kawada N, Imai E, Karber A, Welch WJ, Wilcox CS (2002) A mouse model of angiotensin II slow pressor response: role of oxidative stress. J Am Soc Nephrol 13:2860\u20132868","journal-title":"J Am Soc Nephrol"},{"key":"2488_CR14","doi-asserted-by":"publisher","first-page":"37250","DOI":"10.1074\/jbc.M105275200","volume":"276","author":"JJ Khatri","year":"2001","unstructured":"Khatri JJ, Joyce KM, Brozovich FV, Fisher SA (2001) Role of myosin phosphatase isoforms in cGMP-mediated smooth muscle relaxation. J Biol Chem 276:37250\u201337257","journal-title":"J Biol Chem"},{"key":"2488_CR15","first-page":"175","volume":"38","author":"D Kim","year":"2005","unstructured":"Kim D, Aizawa T, Wei H, Pi X, Rybalkin SD, Berk BC, Yan C (2005) Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which angiotensin II antagonizes cGMP signaling. JMCC 38:175\u2013184","journal-title":"JMCC"},{"key":"2488_CR16","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1161\/HYP.0000000000000090","volume":"73","author":"LO Lerman","year":"2019","unstructured":"Lerman LO, Kurtz TW, Touyz RM, Ellison DH, Chade AR, Crowley SD, Mattson DL, Mullins JJ, Osborn J, Eirin A, Reckelhoff JF, Iadecola C, Coffman TM (2019) Animal models of hypertension: a scientific statement from the American Heart Association. Hypertension 73:e87\u2013e120","journal-title":"Hypertension"},{"key":"2488_CR17","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1172\/JCI131048","volume":"130","author":"G Li","year":"2020","unstructured":"Li G, Wang M, Caulk AW, Cilfone NA, Gujja S, Qin L, Chen P-Y, Chen Z, Yousef S, Jiao Y, He C, Jiang B, Korneva A, Bersi MR, Wang G, Liu X, Mehta S, Geirsson A, Gulcher JR, Chittenden TW, Simons M, Humphrey JD, Tellides G (2020) Chronic mTOR activation induces a degradative smooth muscle cell phenotype. J Clin Invest 130:1233\u20131251","journal-title":"J Clin Invest"},{"key":"2488_CR18","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrd4623","volume":"14","author":"JO Lundberg","year":"2015","unstructured":"Lundberg JO, Gladwin MT, Weitzberg E (2015) Strategies to increase nitric oxide signalling in cardiovascular disease. Nat Rev Drug Discov 14:623\u2013641","journal-title":"Nat Rev Drug Discov"},{"key":"2488_CR19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1046\/j.1440-1681.2000.03240.x","volume":"27","author":"N Marsh","year":"2000","unstructured":"Marsh N, Marsh A (2000) A short history of nitroglycerine and nitric oxide in pharmacology and physiology. Clin Exp Pharmacol Physiol 27:313\u2013319","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2488_CR20","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.1073\/pnas.0802128105","volume":"105","author":"SK Michael","year":"2008","unstructured":"Michael SK, Surks HK, Wang Y, Zhu Y, Blanton R, Jamnongjit M, Aronovitz M, Baur W, Ohtani K, Wilkerson MK, Bonev AD, Nelson MT, Karas RH, Mendelsohn ME (2008) High blood pressure arising from a defect in vascular function. Proc Natl Acad Sci 105:6702\u20136707","journal-title":"Proc Natl Acad Sci"},{"key":"2488_CR21","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.tibtech.2019.03.008","volume":"37","author":"KA Molla","year":"2019","unstructured":"Molla KA, Yang Y (2019) CRISPR\/Cas-mediated base editing: technical considerations and practical applications. Trends Biotechnol 37:1121\u20131142","journal-title":"Trends Biotechnol"},{"key":"2488_CR22","doi-asserted-by":"publisher","first-page":"E58","DOI":"10.1161\/01.RES.0000012569.55432.02","volume":"90","author":"H Mollnau","year":"2002","unstructured":"Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K, Munzel T (2002) Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide\/cGMP signaling. Circ Res 90:E58\u2013E65","journal-title":"Circ Res"},{"key":"2488_CR23","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1172\/JCI123462","volume":"129","author":"M Mukohda","year":"2019","unstructured":"Mukohda M, Fang S, Wu J, Agbor LN, Nair AR, Ibeawuchi S-RC HC, Liu X, Lu K-T, Guo D-F, Davis DR, Keen HL, Quelle FW, Sigmund CD (2019) RhoBTB1 protects against hypertension and arterial stiffness by restraining phosphodiesterase 5 activity. J Clin Invest 129:2318\u20132332","journal-title":"J Clin Invest"},{"key":"2488_CR24","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1056\/NEJMra1510067","volume":"375","author":"MA Pfeffer","year":"2016","unstructured":"Pfeffer MA, McMurray JJ (2016) Lessons in uncertainty and humility - clinical trials involving hypertension. N Engl J Med 375:1756\u20131766","journal-title":"N Engl J Med"},{"key":"2488_CR25","doi-asserted-by":"publisher","first-page":"H1468","DOI":"10.1152\/ajpheart.00567.2015","volume":"309","author":"JJ Reho","year":"2015","unstructured":"Reho JJ, Fisher SA (2015) The stress of maternal separation causes misprogramming in the postnatal maturation of rat resistance arteries. Am J Physiol Heart Circ Physiol 309:H1468\u2013H1478","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2488_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1152\/ajpheart.00869.2015","volume":"310","author":"JJ Reho","year":"2016","unstructured":"Reho JJ, Kenchegowda D, Asico LD, Fisher SA (2016) A splice variant of the myosin phosphatase regulatory subunit tunes arterial reactivity and suppresses response to salt loading. Am J Physiol Heart Circ Physiol 310:15","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2488_CR27","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41598-017-01392-1","volume":"7","author":"C Rippe","year":"2017","unstructured":"Rippe C, Zhu B, Krawczyk KK, Bavel EV, Albinsson S, Sj\u00f6lund J, Bakker ENTP, Sw\u00e4rd K (2017) Hypertension reduces soluble guanylyl cyclase expression in the mouse aorta via the Notch signaling pathway. Sci Rep 7:1334","journal-title":"Sci Rep"},{"key":"2488_CR28","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1681\/ASN.2014080816","volume":"26","author":"MA Sparks","year":"2015","unstructured":"Sparks MA, Stegbauer J, Chen D, Gomez JA, Griffiths RC, Azad HA, Herrera M, Gurley SB, Coffman TM (2015) Vascular type 1A angiotensin II receptors control BP by regulating renal blood flow and urinary sodium excretion. J Am Soc Nephrol 26:2953\u20132962","journal-title":"J Am Soc Nephrol"},{"key":"2488_CR29","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1126\/science.286.5444.1583","volume":"286","author":"HK Surks","year":"1999","unstructured":"Surks HK, Mochizuki N, Kasai Y, Georgescu SP, Tang KM, Ito M, Lincoln TM, Mendelsohn ME (1999) Regulation of myosin phosphatase by a specific interaction with cGMP- dependent protein kinase Ialpha. Science 286:1583\u20131587","journal-title":"Science"},{"key":"2488_CR30","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"The Spint Investigators","year":"2015","unstructured":"The Spint Investigators (2015) A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373:2103\u20132116","journal-title":"N Engl J Med"},{"key":"2488_CR31","doi-asserted-by":"publisher","first-page":"F474","DOI":"10.1152\/ajprenal.00376.2016","volume":"312","author":"M Thieme","year":"2017","unstructured":"Thieme M, Sivritas SH, Mergia E, Potthoff SA, Yang G, Hering L, Grave K, Hoch H, Rump LC, Stegbauer J (2017) Phosphodiesterase 5 inhibition ameliorates angiotensin II-dependent hypertension and renal vascular dysfunction. Am J Physiol Ren Physiol 312:F474\u2013F481","journal-title":"Am J Physiol Ren Physiol"},{"key":"2488_CR32","first-page":"e484","volume":"138","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA, Williamson JD, Wright JT (2018) 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 138:e484\u2013e594","journal-title":"Circulation"},{"key":"2488_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nm1666","volume":"14","author":"A Wirth","year":"2008","unstructured":"Wirth A, Benyo Z, Lukasova M, Leutgeb B, Wettschureck N, Gorbey S, Orsy P, Horvath B, Maser-Gluth C, Greiner E, Lemmer B, Schutz G, Gutkind S, Offermanns S (2008) G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nat Med 14:64\u201368","journal-title":"Nat Med"},{"key":"2488_CR34","doi-asserted-by":"crossref","unstructured":"Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, Brauer M, Kutty VR, Gupta R, Wielgosz A, AlHabib KF, Dans A, Lopez-Jaramillo P, Avezum A, Lanas F, Oguz A, Kruger IM, Diaz R, Yusoff K, Mony P, Chifamba J, Yeates K, Kelishadi R, Yusufali A, Khatib R, Rahman O, Zatonska K, Iqbal R, Wei L, Bo H, Rosengren A, Kaur M, Mohan V, Lear SA, Teo KK, Leong D, O'Donnell M, McKee M, Dagenais G (2020) Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet 395: 795\u2013808","DOI":"10.1016\/S0140-6736(19)32008-2"},{"key":"2488_CR35","doi-asserted-by":"publisher","first-page":"C289","DOI":"10.1152\/ajpcell.00304.2014","volume":"308","author":"X Zheng","year":"2015","unstructured":"Zheng X, Reho JJ, Wirth B, Fisher SA (2015) TRA2beta controls Mypt1 exon 24 splicing in the developmental maturation of mouse mesenteric artery smooth muscle. Am J Physiol Cell Physiol 308:C289\u2013C296","journal-title":"Am J Physiol Cell Physiol"}],"container-title":["Pfl\u00fcgers Archiv - European Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-020-02488-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00424-020-02488-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-020-02488-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T15:24:07Z","timestamp":1618500247000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00424-020-02488-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["2488"],"URL":"https:\/\/doi.org\/10.1007\/s00424-020-02488-w","relation":{},"ISSN":["0031-6768","1432-2013"],"issn-type":[{"value":"0031-6768","type":"print"},{"value":"1432-2013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,4]]},"assertion":[{"value":"13 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}